Pembrolizumab promotes degradation of cyclin dependent kinase 6 and suppresses ovarian cancer progression in vitro

Y Yi Wu Z Ziyan Xu (Department of Molecular Genetics and Microbiology, Duke University Medical Center) Z Zuqiang Kou Q Qiuling Ye L Liting Chen B Boyu Gou

Article Details

Volume / Issue Vol. 15, Issue 1
Published July 12, 2025
ISSN 2045-2322
Publisher Nature Portfolio

Journal Info

Scientific Reports

Nature Portfolio

ISSN: 2045-2322 Open Access Life Sciences

Authors (6)

Y

Yi Wu

Z

Ziyan Xu

Department of Molecular Genetics and Microbiology, Duke University Medical Center

Z

Zuqiang Kou

Q

Qiuling Ye

L

Liting Chen

B

Boyu Gou